Early access and regulation

FDA clears six new drugs in time for the new year
FDA clears six new drugs in time for the new year Brings 2012 tally to 39 – the highest for more than 15 years
Year-end FDA approvals for Novartis, GSK drugs
Year-end FDA approvals for Novartis, GSK drugs Agency gives go-ahead to Cushing’s disease treatment Signifor and raxibacumab for inhalational anthrax

[ Previous 20 results ] 1 2 3 4